1. The Toronto Helicobacter pylori Consensus in Context
David Y. Graham 
Gastroenterology 
Volume 151, Issue 1, Pages 9-12 (July 2016)
DOI: /j.gastro
Copyright © Terms and Conditions

2. Figure 1
Helicobacter pylori eradication rates with proton pump inhibitor triple therapy in populations with varying proportions of clarithromycin resistance. Based on a theoretical population where the cure rate is 95% with susceptible infections and 15% with resistant infections.
Gastroenterology  , 9-12DOI: ( /j.gastro )
Copyright © Terms and Conditions

3. Figure 2
Example of one possible set of recommendations for susceptibility-based first-line Helicobacter pylori therapy. This example is based on the premises that it is preferable to minimize the use of unnecessary antibiotics and that proton pump inhibitors, amoxicillin, and third drug triple therapies are usually better tolerated than bismuth quadruple therapy.
Gastroenterology  , 9-12DOI: ( /j.gastro )
Copyright © Terms and Conditions